The global DNA manufacturing market, valued at USD 5.59 billion in 2024, is projected to expand at a robust CAGR of 14.62% between 2025 and 2034, underscoring its pivotal role in next-generation therapeutics, diagnostics, and advanced research platforms. Regional manufacturing trends are emerging as a decisive factor shaping market penetration strategies, with North America, Europe, and Asia Pacific collectively accounting for the bulk of global revenues. Market growth is closely tied to regional healthcare policies, biotechnology funding, and the resilience of cross-border supply chains that support large-scale production
লাইক
মন্তব্য করুন
শেয়ার করুন
